Free public records show ScandiBio Therapeutics AB in 2 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by ScandiBio Therapeutics AB or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
2 active studies led by ScandiBio Therapeutics AB, of 4 in all
Source: ClinicalTrials.gov, Studies with ScandiBio Therapeutics AB (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies ScandiBio Therapeutics AB leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with ScandiBio Therapeutics AB or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show ScandiBio Therapeutics AB: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets ScandiBio Therapeutics AB is in.
Stories on the topics ScandiBio Therapeutics AB works in.
1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence…
Read
2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a…
Read
170 of 194 WHO member states report use of traditional medicine. Herbal products are popular, but quality and…
ReadSearch all reports for ScandiBio Therapeutics AB All companies